In Vitro Pharmacology Scientist — Metabolic Disease & GPCRs

Zealand Pharma U.S., Inc.; Cambridge (MA); Presencial; USD 110.000 - 150.000; Jornada completa

Descripción de la vacante

Zealand Pharma is seeking a Scientist I/II in In Vitro Pharmacology in Cambridge, MA to design, execute, and interpret biochemical, biophysical, and cell-based assays supporting screening and SAR across obesity and metabolic programs.

This hands-on role collaborates with Chemistry, in vivo Pharmacology, DMPK/Safety, and Formulation, helping advance candidates with assay-ready data and expanding automation-enabled HTS capabilities.

Formación

• Ph.D. in related field with 0–3 years of industry or postdoctoral experience.
• M.S. with approximately 3–6 years of industry experience.
• B.S./B.A. with approximately 5–8+ years of industry experience.
• Exceptional candidates may be considered for Senior Scientist I.

Responsabilidades

• Design, develop, optimize, and validate in vitro assays (biochemical, biophysical, and cell-based) to support screening and mechanism studies.
• Generate, analyze, and communicate pharmacological data to enable timely decisions across discovery programs.
• Contribute expertise in GPCR pharmacology and/or metabolic disease biology to develop disease-relevant assays.
• Support implementation of automation, liquid handling, and HTS-enabled workflows to increase throughput and quality.
• Partner with Chemistry, in vivo Pharmacology, DMPK/Safety, and Formulation to align data with candidate needs.
• Maintain rigorous documentation and uphold data quality and scientific integrity.

Conocimientos

GPCR pharmacology

in vitro pharmacology

biochemical assays

cell-based assays

data analysis

Educación

Ph.D. in Pharmacology/Biology/Biochemistry/Cell Biology

M.S. in life sciences

B.S./B.A. in life sciences

Herramientas

Automation platforms

HTS platforms

Descripción del empleo

Zealand Pharma is seeking a Scientist I/II in In Vitro Pharmacology in Cambridge, MA to design, execute, and interpret biochemical, biophysical, and cell-based assays supporting screening and SAR across obesity and metabolic programs.

This hands-on role collaborates with Chemistry, in vivo Pharmacology, DMPK/Safety, and Formulation, helping advance candidates with assay-ready data and expanding automation-enabled HTS capabilities.